Kon Masafumi, Fukami Maki
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Department of Urology, Hokkaido University Graduate School of Medicine, North-15, West-7, Kita-ku, Sapporo, 060-8638, Japan.
Mol Cell Pediatr. 2015 Dec;2(1):7. doi: 10.1186/s40348-015-0018-2. Epub 2015 Apr 30.
Mutations in known causative genes and cytogenetically detectable chromosomal rearrangements account for a fraction of cases with 46,XY disorders of sex development (DSD). Recent advances in molecular cytogenetic technologies, including array-based comparative genomic hybridization (aCGH) and multiplex ligation-dependent probe amplification (MLPA), have enabled the identification of copy-number variations (CNVs) in individuals with apparently normal karyotypes.
This review paper summarizes the results of 15 recent studies, in which aCGH or MLPA were used to identify CNVs. Several submicroscopic CNVs have been detected in patients with 46,XY DSD. These CNVs included deletions involving known causative genes such as DMRT1 or NR5A1, duplications involving NR0B1, deletions involving putative cis-regulatory elements of SOX9, and various deletions and duplications of unknown pathogenicity.
The results of recent studies highlight the significance of submicroscopic CNVs as the genetic basis of 46,XY DSD. Molecular cytogenetic analyses should be included in the diagnostic workup of patients with 46,XY DSD of unknown origin. Further studies using aCGH will serve to clarify novel causes of this condition.
已知致病基因的突变和细胞遗传学可检测到的染色体重排仅占46,XY性发育障碍(DSD)病例的一部分。包括基于阵列的比较基因组杂交(aCGH)和多重连接依赖探针扩增(MLPA)在内的分子细胞遗传学技术的最新进展,使得能够在核型看似正常的个体中鉴定拷贝数变异(CNV)。
这篇综述文章总结了最近15项研究的结果,这些研究使用aCGH或MLPA来鉴定CNV。在46,XY DSD患者中检测到了几个亚显微CNV。这些CNV包括涉及已知致病基因(如DMRT1或NR5A1)的缺失、涉及NR0B1的重复、涉及SOX9假定顺式调控元件的缺失以及各种致病性未知的缺失和重复。
最近的研究结果突出了亚显微CNV作为46,XY DSD遗传基础的重要性。对于病因不明的46,XY DSD患者,分子细胞遗传学分析应纳入诊断检查。使用aCGH的进一步研究将有助于阐明这种疾病的新病因。